1 / 73

Dementia Drugs Market

Dementia Drugs Market, By Drug Class (Cholinesterase Inhibitors, MAO Inhibitors, and Glutamate Inhibitors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Trends, Analysis and Forecast till 2029

ankita73
Download Presentation

Dementia Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dementia Drugs Market: Global Industry, Size, Share, Growth, Trends and Forecast, 2019–2029 August 2019 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  2. Report Snippet Chapter 1 : Table of Contents Chapter 2: Market Purview Chapter 4: Global Dementia Drugs Market, By Drug Class Chapter 3: Market Dynamics Chapter 5: Global Dementia Drugs Market, By Distribution Channel Chapter 6: Global Dementia Drugs Market, By Region Chapter 7: Competitive Analysis Chapter 8: Company Profiles 2 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  3. Table of Contents Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved 3

  4. Table of Content Sr. No. Content 1.0 Chapter 1 1.0.1 Preface 1.0.2 Research Objective and Assumption 1.0.3 Abbreviation 2.0 Chapter 2 2.0.1 Market Purview 2.1 Report Description 2.1.1 Market Definition and Scope 2.2 Executive Summary 2.2.1 Market Snippet, By Drug Class 2.2.2 Market Snippet, By Distribution Channel 2.2.3 Market Snippet, By Region 2.2.4 Opportunity Map Analysis 3.0 Chapter 3 3.1.1 Drivers (D) 3.1.2 Restrains (R) Secondary Source Primary Source Prophecy Analysis 4 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  5. Table of Content Sr. No. Content 3.1.3 Opportunities 3.1.4 Trends 3.1.5 DR Impact Analysis 3.1.6 Opportunity Orbit 3.1.7 PEST Analysis 3.1.8 Porter’s Five Forces Analysis 4.0 Chapter 4 4.0.1 Global Dementia Drugs Market Value (US$ Mn), By Drug Class 4.0.2 Segment Overview 4.0.3 Market Value and Forecast (US$ Mn), and Share (%) Analysis, 2018 – 2029 4.0.4 Y-o-Y Growth (%) Analysis, 2019 – 2029 4.1 Cholinesterase Inhibitors 4.1.1 Overview 4.1.2 Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%) Analysis, 2018 – 2029 4.2 MAO Inhibitors 4.2.1 Overview Secondary Source Primary Source Prophecy Analysis 5 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  6. Table of Content Sr. No. Content 4.2.2 Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%) Analysis, 2018 – 2029 4.3 Glutamate Inhibitors 4.3.1 Overview 4.3.2 Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%) Analysis, 2018 – 2029 5.0 Chapter 5 5.0.1 Global Dementia Drugs Market Value (US$ Mn), By Distribution Channel 5.0.2 Segment Overview 5.0.3 Market Value and Forecast (US$ Mn), and Share (%) Analysis, 2018 – 2029 5.0.4 Y-o-Y Growth (%) Analysis, 2019 – 2029 5.1 Hospital Pharmacy 5.1.1 Overview 5.1.2 Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%) Analysis, 2018 – 2029 5.2 Retail Pharmacy 5.2.1 Overview 5.2.2 Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%) Analysis, 2018 – 2029 5.3 Online Channel Secondary Source Primary Source Prophecy Analysis 6 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  7. Table of Content Sr. No. Content 5.3.1 Overview 5.3.2 Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%) Analysis, 2018 – 2029 6.0 Chapter 6 6.0 Global Dementia Drugs Market Value (US$ Mn), By Region 6.0.1 Overview 6.0.2 Market Value and Forecast (US$ Mn), and Share (%) Analysis, 2018 – 2029 6.0.3 Market Share (%) and BPS Analysis, By Region 6.0.4 Y-o-Y Growth (%) Analysis, 2019 – 2029 6.1 North America 6.1.1 Overview 6.1.2 Market Value and Forecast (US$ Mn), 2018 – 2029 6.1.3 North America Botanical and Plant-Derived Drugs Market, By Source 6.1.4 North America Botanical and Plant-Derived Drugs Market, By Dosage Form 6.1.5 North America Botanical and Plant-Derived Drugs Market, By Country 6.1.6 U.S. 6.1.6.1 Market Value and Forecast (US$ Mn), 2018 – 2029 Secondary Source Primary Source Prophecy Analysis 7 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  8. Table of Content Sr. No. Content 6.1.7 Canada 6.1.7.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.2 Europe 6.2.1 Overview 6.2.2 Market Value and Forecast (US$ Mn), 2018 – 2029 6.2.3 Europe Botanical and Plant-Derived Drugs Market, By Source 6.2.4 Europe Botanical and Plant-Derived Drugs Market, By Dosage Form 6.2.5 Europe Botanical and Plant-Derived Drugs Market, By Country 6.2.6 Germany 6.2.6.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.2.7 UK 6.2.7.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.2.8 France 6.2.8.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.2.9 Russia 6.2.9.1 Market Value and Forecast (US$ Mn), 2018 – 2029 Secondary Source Primary Source Prophecy Analysis 8 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  9. Table of Content Sr. No. Content 6.2.10 Italy 6.2.10.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.2.11 Rest of Europe 6.2.11.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.3 Asia Pacific 6.3.1 Overview 6.3.2 Market Value and Forecast (US$ Mn), 2018 – 2029 6.3.3 Asia Pacific Botanical and Plant-Derived Drugs Market, By Source 6.3.4 Asia Pacific Botanical and Plant-Derived Drugs Market, By Dosage Form 6.3.5 Asia Pacific Botanical and Plant-Derived Drugs Market, By Country 6.3.6 China 6.3.6.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.3.7 India 6.3.7.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.3.8 Japan 6.3.8.1 Market Value and Forecast (US$ Mn), 2018 – 2029 Secondary Source Primary Source Prophecy Analysis 9 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  10. Table of Content Sr. No. Content 6.3.9 South Korea 6.3.9.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.3.10 Rest of Asia-Pacific 6.3.10.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.4 Latin America 6.4.1 Overview 6.4.2 Market Value and Forecast (US$ Mn), 2018 – 2029 6.4.3 Latin America Botanical and Plant-Derived Drugs Market, By Source 6.4.4 Latin America Botanical and Plant-Derived Drugs Market, By Dosage Form 6.4.5 Latin America Botanical and Plant-Derived Drugs Market, By Country 6.4.6 Brazil 6.4.6.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.4.7 Mexico 6.4.7.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.4.8 Rest of Latin America 6.4.8.1 Market Value and Forecast (US$ Mn), 2018 – 2029 Secondary Source Primary Source Prophecy Analysis 10 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  11. Table of Content Sr. No. Content 6.5 Middle East & Africa 6.5.1 Overview 6.5.2 Market Value and Forecast (US$ Mn), 2018 – 2029 6.5.3 Middle East & Africa Botanical and Plant-Derived Drugs Market, By Source 6.5.4 Middle East & Africa Botanical and Plant-Derived Drugs Market, by Dosage Form 6.5.5 Middle East & Africa Botanical and Plant-Derived Drugs Market, By Country 6.5.6 GCC 6.5.6.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.5.7 Israel 6.5.7.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.5.8 South Africa 6.5.8.1 Market Value and Forecast (US$ Mn), 2018 – 2029 6.5.9 Rest of Middle East & Africa 6.5.9.1 Market Value and Forecast (US$ Mn), 2018 – 2029 7.0 Chapter 7 7.0.1 Competitive Analysis Secondary Source Primary Source Prophecy Analysis 11 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  12. Table of Content Sr. No. Content 7.0.2 Competitive Overview 7.0.3 Heat Map Analysis 7.0.4 Market Presence and Specificity Analysis 8.0 Chapter 8 8.0.1 Company Profiles 8.0.2 Heat Map Analysis 8.1 Eli Lilly & Company 8.1.1 Company Overview 8.1.2 Product Portfolio 8.1.3 Key Highlights 8.1.4 Financial Overview 8.2 Cadila Healthcare Ltd. 8.2.1 Company Overview 8.2.2 Product Portfolio 8.2.3 Key Highlights 8.2.4 Financial Overview Secondary Source Primary Source Prophecy Analysis 12 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  13. Table of Content Sr. No. Content 8.3 Janssen Pharmaceuticals., Inc. 8.3.1 Company Overview 8.3.2 Product Portfolio 8.3.3 Key Highlights 8.3.4 Financial Overview 8.4 Eisai Co. Ltd. 8.4.1 Company Overview 8.4.2 Product Portfolio 8.4.3 Key Highlights 8.4.4 Financial Overview 8.5 Novartis AG 8.5.1 Company Overview 8.5.2 Product Portfolio 8.5.3 Key Highlights 8.5.4 Financial Overview 8.6 Forest Laboratories, Inc. Secondary Source Primary Source Prophecy Analysis 13 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  14. Table of Content Sr. No. Content 8.6.1 Company Overview 8.6.2 Product Portfolio 8.6.3 Key Highlights 8.6.4 Financial Overview 8.7 Hoffmann-La Roche., Inc. 8.7.1 Company Overview 8.7.2 Product Portfolio 8.7.3 Key Highlights 8.7.4 Financial Overview 8.7.5 Merck & Co., Inc 8.8 Company Overview 8.8.1 Product Portfolio 8.8.2 Key Highlights 8.8.3 Financial Overview 8.9 Valeant Pharmaceutical International 8.9.1 Company Overview Secondary Source Primary Source Prophecy Analysis 14 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  15. Table of Content Sr. No. Content 8.9.2 Product Portfolio 8.9.3 Key Highlights 8.9.4 Financial Overview 8.10 Pfizer Inc. 8.10.1 Company Overview 8.10.2 Product Portfolio 8.10.3 Key Highlights 8.10.4 Financial Overview 9.0 Chapter 9 9.0.1 Research Methodology 9.0.2 About Us *The content/data is provided for illustration purpose only and is subject to change in the final version of the report Secondary Source Primary Source Prophecy Analysis 15 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  16. Chapter 01 Preface Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved 16

  17. Preface Market Definition and Scope  Global Dementia Drugs Market is segmented on the basis of Drug Class, Distribution Channel, and Region.  By Drug Class: Cholinesterase Inhibitors, MAO Inhibitors, and Glutamate Inhibitors  By DistributionChannel: Hospital Pharmacy, Retail Pharmacy, and Online Channel  By Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Arica  Scope of The Report: This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc. The report also serves to offer insights for investors to understand the specific industry, market, and make strategic decisions. In addition, it will serve to gain insights regarding the various players in the market, their financials, recent developments, and strategies adopted and employed in terms of expansion, mergers and acquisitions, collaborations, strategic agreements and contracts etc., as well as product offerings.  Analytical framework involves pest analysis and porters of the target market  Sourcingof the data throughoutthe report includes : extensive primary and secondary research data analysis Source: Prophecy Market Insights 17 Copyright © PROPHECY 2019, All Rights Reserved

  18. Research Objective and Assumption Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved 18

  19. Research Objectives and Assumptions Research Objectives Assumptions Source: Prophecy Market Insights 19 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  20. Abbreviations Abbreviation and Full Form Abbreviation Full Form Mn Million Bn Billion US$ US Dollar CAGR Compounded Annual Growth Rate Y-o-Y Year on Year APAC Asia Pacific MEA Middle East and Africa Source: Prophecy Market Insights 20 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  21. Chapter 02 Market Purview 2 1 Copyright © PROPHECY 2019, All Rights Reserved

  22. Market Segmentation Global Dementia Drugs Market By Drug Class By Distribution Channel By Region  North America  Europe  Asia Pacific  Latin America  Middle East & Africa  Cholinesterase Inhibitors  MAO Inhibitors  Glutamate Inhibitors  Hospital Pharmacy  Retail Pharmacy  Online Channel Source: Prophecy Market Insights 22 Copyright © PROPHECY 2019, All Rights Reserved

  23. Report Description Report Description 23 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  24. Executive Summary (1/3) Table 2.1: Global Dementia Drugs Market Overview Parameters 2019 (E) 2029 (F) Global Dementia Drugs Market Value (US$ Mn) XXX.X XXX.X Drug Class Segment with Largest Value (US$ Mn) MAO Inhibitors : XXX.X MAO Inhibitors : XXX.X Drug Class Segment with Highest CAGR (%)-2019-2029 MAO Inhibitors : CAGR- XX.X DistributionChannel Segment with Largest Value (US$ Mn) Hospital Pharmacy : XXX.X Hospital Pharmacy : XXX.X Distribution Channel Segment with Highest CAGR (%)-2019- 2029 Hospital Pharmacy : CAGR- XX.X Region with Largest Value (US$ Mn) North America : XXX.X North America : XXX.X Region with Highest CAGR (%)-2019-2029 North America : CAGR- XX.X Eli Pharmaceuticals, Inc., Eisai Co., Ltd., Novartis AG, Forest Laboratories, Inc., Hoffmann-La Roche., Merck & Co., Inc., Valeant Pharmaceutical International, and Pfizer Inc. Lilly & Company, Cadila Healthcare Ltd., Janssen Key Market Players: Source: Prophecy Market Insights 24 Copyright © PROPHECY 2019, All Rights Reserved

  25. Executive Summary (2/3) Figure 2.1: Global Dementia Drugs Market Value Share (%), By Drug Class – 2019 (E) Description  Growing incidence rate of alzheimer’s disease among the global population along with substantial engagement of various key players in gaining regulatory product approval is majorly driving the global dementia drug market Cholinesterase Inhibitors MAO Inhibitors XX.X% Glutamate Inhibitors Analysis  By drug class, the MAO inhibitors segment is accounted for major value share XX.X% in 2019. The XYZ segment is accounted for the second highest value share XX.X% in 2019 in the target market. Source: Prophecy Market Insights 25 Copyright © PROPHECY 2019, All Rights Reserved

  26. Executive Summary (3/3) Figure 2.2: Global Dementia Drugs Market Value Share (%), By Distribution Channel– 2019 (E) Figure 2.3: Global Dementia Drugs Market Value Share (%), By Region – 2019 (E) North America Online Channel Europe XX.X% XX.X% Asia Pacific Retail Pharmacy Latin America Hospital Pharmacy Middle East & Africa Analysis and Outcomes Source: Prophecy Market Insights 26 Copyright © PROPHECY 2019, All Rights Reserved

  27. Opportunity Map Analysis Opportunity Map Analysis, by Market Value (US$ Mn) and CAGR (%) Analysis and Outcome CAGR XX.X% 1720.0 XX.X% 1520.0 XX.X% 1320.0 XXX.X XXX.X XXX.X 1120.0 920.0 720.0 520.0 Conservative Optimistic 320.0 Likely 120.0 Likely Conservative Optimistic Market Value (US$ Mn) - 2029 Source: Prophecy Market Insights 27 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  28. Chapter 03 Market Dynamics Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved 28

  29. Market Dynamics Drivers Restraints Opportunity Larger number of pipeline drugs in the treatment of dementia Growing incidence rate of alzheimer’s disease among the global population 1 High cost of prospective drugs to be marketed 1 1 2 2 ABC ABC 3 XYZ Source: Prophecy Market Insights 29 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  30. Drivers Growing incidence rate of alzheimer’s disease among the global population Source: Prophecy Market Insights 30 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  31. Drivers ABC Source: Prophecy Market Insights 31 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  32. Drivers XYZ Source: Prophecy Market Insights 32 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  33. Restraints High cost of prospective drugs to be marketed ABC Source: Prophecy Market Insights 33 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  34. Opportunity Larger number of pipeline drugs in the treatment of dementia Source: Prophecy Market Insights 34 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  35. Trend ABC Source: Prophecy Market Insights 35 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  36. Drivers and Restraints Impact Analysis Drivers Growing incidence rate of alzheimer’s disease among the global population High D1 D2 ABC Impact on Market Growth Rate D1 XYZ D3 D2 Likely Growth Sample for Illustration Purpose Restraints R1 High cost of prospective drugs to be marketed D3 R1 ABC R2 D4 R2 Low Low Impact on Market Value High Source: Prophecy Market Insights 36 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  37. Opportunity Orbit Source: Prophecy Market Insights 37 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  38. PEST Analysis (1/4) Political Analysis POLITICAL ECONOMICAL SOCIAL TECHNOLOGICAL Source: Prophecy Market Insights 38 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  39. PEST Analysis (2/4) Economical Analysis POLITICAL ECONOMICAL SOCIAL TECHNOLOGICAL Source: Prophecy Market Insights 39 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  40. PEST Analysis (3/4) Social Analysis POLITICAL ECONOMICAL SOCIAL TECHNOLOGICAL Source: Prophecy Market Insights 40 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  41. PEST Analysis (4/4) Technological Analysis POLITICAL ECONOMICAL SOCIAL TECHNOLOGICAL Source: Prophecy Market Insights 41 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  42. PORTER’S Five Forces Analysis Buyer Power-moderate Threat of New Entrants- High Rivalry-High Supplier Power-Moderate Threat Moderate of Substitutes- Source: Prophecy Market Insights 42 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  43. Chapter 04 Global Dementia Drugs Market, By Drug Class 43 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  44. Global Dementia Drugs Market, By Drug Class Table 4.1: Global Dementia Drugs Market Value and Forecast (US$ Mn), By Drug Class - 2018–2029 CAGR (2018– 29) Drug Class 2018 A 2019 E 2020 F 2021 F 2022 F 2023 F 2024 F 2025 F 2026 F 2027 F 2028 F 2029 F Cholinesterase Inhibitors XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X MAO Inhibitors XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X Glutamate Inhibitors XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X Total XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X Source: Prophecy Market Insights 44 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  45. Global Dementia Drugs Market, By Drug Class Figure 4.1 : Global Dementia Drugs Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%), by Drug Class - 2018-2029 Analysis and Outcome  The global dementia drugs market by drug class segment was valued US$ XXX.X Mn in 2018 and is expected to reach US$ XXX.X Mn in 2029, and register a CAGR of XX.X% over the forecast period 1,200.0 4.7% 4.6% 4.5% 4.4% 4.3% 4.2% 4.1% 4.0% 1,000.0 3.9% 3.8% 3.7% 3.6%  The first six year (2018-2023) cumulative value is projected to be US$ XXX.X Mn, as compared to relatively higher cumulative value of US$ XXX.X Mn for the last six year (2024-2029) of the forecast period 3.5% 3.4% 3.3% 3.2% 800.0 3.1% 3.0% 2.9% 2.8% 2.7% 2.6% 2.5% 2.4% 600.0 2.3%  The MAO inhibitors drug class segment accounted for value share XX.X in 2019 and is expected to increase to XX.X% in 2029 2.2% 2.1% 2.0% 1.9% 1.8% 1.7% 1.6% 400.0 1.5% 1.4% 1.3% 1.2% 1.1% 1.0% 0.9% 0.8% 200.0 0.7% 0.6% 0.5% 0.4% 0.3% 0.2% 0.1% - 0.0% 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Value Y-O-Y X.XX Projected growth between 2019 and 2029 Source: Prophecy Market Insights 45 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  46. Cholinesterase Inhibitors Figure 4.2: Global Dementia Drugs Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%), by Cholinesterase Inhibitors- 2018-2029 Analysis and Outcome 350.0 5.0% 300.0 250.0 3.0% 200.0 150.0 1.0% 100.0 50.0 - -1.0% 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Value Y-O-Y X.XX Projected growth between 2019 and 2029 Source: Prophecy Market Insights 46 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  47. MAO Inhibitors Figure 4.3 : Global Dementia Drugs Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%), by MAO Inhibitors- 2018-2029 Analysis and Outcome 450.0 5.2% 4.8% 400.0 4.4% 350.0 4.0% 3.6% 300.0 3.2% 250.0 2.8% 2.4% 200.0 2.0% 150.0 1.6% 1.2% 100.0 0.8% 50.0 0.4% - 0.0% 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Value Y-O-Y X.XX Projected growth between 2019 and 2029 Source: Prophecy Market Insights 47 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  48. Glutamate Inhibitors Figure 4.4 : Global Dementia Drugs Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%), by Glutamate Inhibitors- 2018-2029 Analysis and Outcome 300.0 4.5% 4.0% 250.0 3.5% 200.0 3.0% 2.5% 150.0 2.0% 100.0 1.5% 1.0% 50.0 0.5% - 0.0% 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Value Y-O-Y X.XX Projected growth between 2019 and 2029 Source: Prophecy Market Insights 48 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  49. Chapter 06 Global Dementia Drugs Market, By Region Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

  50. Region Overview Figure 6.1: Global Dementia Drugs Market Value Share (%) By Region -2019 XX.X% XX.X% XX.X% X.X% XX.X% Source: Prophecy Market Insights 50 Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved

More Related